1,2-dichloroethane increases expression ISO RGD:1331929 6480464 ethylene dichloride results in increased expression of SLC16A10 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine affects expression ISO RGD:1331929 6480464 1, 2-Dimethylhydrazine affects the expression of SLC16A10 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:731538 6480464 Dinitrochlorobenzene results in increased expression of SLC16A10 mRNA CTD PMID:17374397 1-nitropropane increases expression EXP 6480464 1-nitropropane results in increased expression of SLC16A10 mRNA CTD PMID:17070881 17beta-estradiol decreases expression ISO RGD:731538 6480464 Estradiol results in decreased expression of SLC16A10 mRNA CTD PMID:20106945 17beta-estradiol increases expression ISO RGD:731538 6480464 Estradiol results in increased expression of SLC16A10 mRNA CTD PMID:31614463 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731538 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1331929 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of SLC16A10 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC16A10 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1331929 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A10 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1331929 6480464 Tetrachlorodibenzodioxin affects the expression of SLC16A10 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731538 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC16A10 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC16A10 mRNA CTD PMID:21215274 2,4-diaminotoluene decreases expression EXP 6480464 2, 4-diaminotoluene results in decreased expression of SLC16A10 mRNA CTD PMID:17070881 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC16A10 mRNA CTD PMID:21346803 2,6-diaminotoluene increases expression EXP 6480464 2, 6-diaminotoluene results in increased expression of SLC16A10 mRNA CTD PMID:17070881 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene results in decreased expression of SLC16A10 mRNA CTD PMID:17070881 2-nitro-p-phenylenediamine decreases expression EXP 6480464 2-nitro-4-phenylenediamine results in decreased expression of SLC16A10 mRNA CTD PMID:17070881 2-nitropropane decreases expression EXP 6480464 2-nitropropane results in decreased expression of SLC16A10 mRNA CTD PMID:17070881 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1331929 6480464 3 more ... CTD PMID:19467301 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC16A10 mRNA CTD PMID:28522335 4-acetylaminofluorene increases expression EXP 6480464 4-acetylaminofluorene results in increased expression of SLC16A10 mRNA CTD PMID:17070881 4-nitro-1,2-phenylenediamine decreases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in decreased expression of SLC16A10 mRNA CTD PMID:17070881 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLC16A10 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:731538 6480464 Aflatoxin B1 affects the expression of SLC16A10 protein CTD PMID:20106945 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC16A10 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:731538 6480464 Aflatoxin B1 results in increased methylation of SLC16A10 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:731538 6480464 Aflatoxin B1 results in decreased expression of SLC16A10 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1331929 6480464 Aflatoxin B1 results in decreased expression of SLC16A10 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:731538 6480464 Tretinoin results in increased expression of SLC16A10 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:731538 6480464 Tretinoin results in decreased expression of SLC16A10 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC16A10 mRNA CTD PMID:16483693 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC16A10 gene CTD PMID:28931070 azathioprine decreases expression ISO RGD:731538 6480464 Azathioprine results in decreased expression of SLC16A10 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1331929 6480464 Benzo(a)pyrene results in decreased expression of SLC16A10 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:731538 6480464 Benzo(a)pyrene results in decreased expression of SLC16A10 mRNA CTD PMID:32234424 benzo[b]fluoranthene decreases expression ISO RGD:1331929 6480464 benzo(b)fluoranthene results in decreased expression of SLC16A10 mRNA CTD PMID:26377693 beta-naphthoflavone decreases expression ISO RGD:731538 6480464 beta-Naphthoflavone results in decreased expression of SLC16A10 mRNA CTD PMID:32858204 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC16A10 mRNA CTD PMID:25181051 , PMID:34947998 capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of SLC16A10 mRNA CTD PMID:16278290 carbon nanotube affects expression ISO RGD:1331929 6480464 Nanotubes, Carbon affects the expression of SLC16A10 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1331929 6480464 Nanotubes, Carbon analog results in increased expression of SLC16A10 mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:731538 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC16A10 gene] CTD PMID:28238834 chlordecone decreases expression ISO RGD:1331929 6480464 Chlordecone results in decreased expression of SLC16A10 mRNA CTD PMID:33711761 chlorpyrifos increases expression ISO RGD:1331929 6480464 Chlorpyrifos results in increased expression of SLC16A10 mRNA CTD PMID:32715474 choline multiple interactions ISO RGD:1331929 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC16A10 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1331929 6480464 chromium hexavalent ion affects the expression of SLC16A10 mRNA CTD PMID:28472532 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC16A10 mRNA CTD PMID:17602206 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of SLC16A10 mRNA CTD PMID:27899881 copper atom multiple interactions ISO RGD:731538 6480464 [Disulfiram binds to Copper] which results in decreased expression of SLC16A10 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of SLC16A10 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) multiple interactions ISO RGD:731538 6480464 [Disulfiram binds to Copper] which results in decreased expression of SLC16A10 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of SLC16A10 mRNA CTD PMID:20971185 , PMID:24690739 copper(II) sulfate decreases expression ISO RGD:731538 6480464 Copper Sulfate results in decreased expression of SLC16A10 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:731538 6480464 Cyclosporine results in decreased expression of SLC16A10 mRNA CTD PMID:20106945 , PMID:25562108 dicrotophos decreases expression ISO RGD:731538 6480464 dicrotophos results in decreased expression of SLC16A10 mRNA CTD PMID:28302478 diethyl hydrogen phosphate decreases expression EXP 6480464 diethyl phosphate results in decreased expression of SLC16A10 mRNA CTD PMID:31835022 dioxygen increases expression ISO RGD:1331929 6480464 Oxygen deficiency results in increased expression of SLC16A10 mRNA CTD PMID:22629407 dioxygen multiple interactions ISO RGD:1331929 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SLC16A10 mRNA] CTD PMID:22629407 disulfiram multiple interactions ISO RGD:731538 6480464 [Disulfiram binds to Copper] which results in decreased expression of SLC16A10 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:731538 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC16A10 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:731538 6480464 Doxorubicin results in increased expression of SLC16A10 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:731538 6480464 entinostat results in increased expression of SLC16A10 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1331929 6480464 epoxiconazole results in increased expression of SLC16A10 mRNA CTD PMID:35436446 eugenol increases expression ISO RGD:731538 6480464 Eugenol results in increased expression of SLC16A10 mRNA CTD PMID:17374397 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC16A10 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1331929 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC16A10 gene CTD PMID:20938992 fonofos increases methylation ISO RGD:731538 6480464 Fonofos results in increased methylation of SLC16A10 promoter CTD PMID:22847954 furan decreases expression EXP 6480464 furan results in decreased expression of SLC16A10 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1331929 6480464 Genistein results in increased expression of SLC16A10 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC16A10 mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC16A10 mRNA CTD PMID:33387578 L-methionine multiple interactions ISO RGD:1331929 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC16A10 gene CTD PMID:20938992 metformin decreases expression EXP 6480464 Metformin results in decreased expression of SLC16A10 mRNA CTD PMID:31324951 methotrexate affects expression ISO RGD:1331929 6480464 Methotrexate affects the expression of SLC16A10 mRNA CTD PMID:18502557 methylisothiazolinone increases expression ISO RGD:731538 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of SLC16A10 mRNA CTD PMID:31629900 N-nitrosodiethylamine increases expression ISO RGD:1331929 6480464 Diethylnitrosamine results in increased expression of SLC16A10 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC16A10 mRNA CTD PMID:17602206 N-nitrosodiethylamine multiple interactions ISO RGD:1331929 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC16A10 mRNA] CTD PMID:17942915 nickel atom decreases expression ISO RGD:731538 6480464 Nickel results in decreased expression of SLC16A10 mRNA CTD PMID:24768652 nickel sulfate increases expression ISO RGD:731538 6480464 nickel sulfate results in increased expression of SLC16A10 mRNA CTD PMID:16780908 , PMID:17374397 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of SLC16A10 mRNA CTD PMID:23665939 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC16A10 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC16A10 mRNA CTD PMID:25729387 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of SLC16A10 mRNA CTD PMID:23439660 paracetamol affects expression ISO RGD:1331929 6480464 Acetaminophen affects the expression of SLC16A10 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC16A10 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:731538 6480464 Parathion results in increased methylation of SLC16A10 promoter CTD PMID:22847954 phenformin increases expression EXP 6480464 Phenformin results in increased expression of SLC16A10 mRNA CTD PMID:31324951 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of SLC16A10 mRNA CTD PMID:18158353 pirinixic acid decreases expression ISO RGD:1331929 6480464 pirinixic acid results in decreased expression of SLC16A10 mRNA CTD PMID:23811191 propanal increases expression ISO RGD:731538 6480464 propionaldehyde results in increased expression of SLC16A10 mRNA CTD PMID:26079696 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC16A10 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:731538 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC16A10 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:731538 6480464 Silicon Dioxide analog results in decreased expression of SLC16A10 mRNA CTD PMID:25895662 sodium arsenate increases expression ISO RGD:1331929 6480464 sodium arsenate results in increased expression of SLC16A10 mRNA CTD PMID:21795629 sunitinib increases expression ISO RGD:731538 6480464 Sunitinib results in increased expression of SLC16A10 mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:731538 6480464 terbufos results in increased methylation of SLC16A10 promoter CTD PMID:22847954 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC16A10 mRNA, Carbon Tetrachloride results in decreased expression of SLC16A10 protein CTD PMID:17544377 , PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1331929 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of SLC16A10 mRNA CTD PMID:29987408 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC16A10 mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC16A10 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC16A10 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC16A10 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:731538 6480464 trichostatin A results in decreased expression of SLC16A10 mRNA CTD PMID:24935251 trichostatin A increases expression ISO RGD:731538 6480464 trichostatin A results in increased expression of SLC16A10 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:731538 6480464 Triclosan results in decreased expression of SLC16A10 mRNA CTD PMID:30510588 triptonide increases expression ISO RGD:1331929 6480464 triptonide results in increased expression of SLC16A10 mRNA CTD PMID:33045310 urethane increases expression ISO RGD:731538 6480464 Urethane results in increased expression of SLC16A10 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:731538 6480464 Valproic Acid affects the expression of SLC16A10 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:731538 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC16A10 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731538 6480464 Valproic Acid results in increased expression of SLC16A10 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:731538 6480464 Valproic Acid results in decreased methylation of SLC16A10 gene CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC16A10 mRNA CTD PMID:23034163 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of SLC16A10 gene CTD PMID:31682807 vorinostat increases expression ISO RGD:731538 6480464 vorinostat results in increased expression of SLC16A10 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO RGD:731538 6480464 zoledronic acid results in increased expression of SLC16A10 mRNA CTD PMID:24714768